Axsome Therapeutics, Inc. (AXSM)
145.31
-3.44
(-2.31%)
USD |
NASDAQ |
Dec 12, 10:52
Axsome Therapeutics Free Cash Flow: -101.39M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Fortress Biotech, Inc. | -30.14M |
| TG Therapeutics, Inc. | -70.24M |
| Karyopharm Therapeutics, Inc. | -89.30M |
| Viking Therapeutics, Inc. | -224.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.046M |
| Cash from Investing (Quarterly) | -0.058M |
| Cash from Financing (Quarterly) | 21.27M |
| Free Cash Flow Per Share (Quarterly) | 0.0198 |
| Free Cash Flow to Equity (Quarterly) | 5.778M |
| Free Cash Flow to Firm (Quarterly) | 4.363M |
| Free Cash Flow Yield | -1.42% |